skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration
Pharmaceutical companies face many challenges in Japan in terms of its complex regulatory and pricing process. Regular price cuts also pose hurdles for the introduction of new innovative drugs. Despite these challenges, the world’s second largest pharmaceutical market presents a number of opportunities.

Highlights in this white paper include:

  • The result of the measures taken by Japan to reduce the drug lag period
  • A discussion into the difficulties in obtaining price premiums at launch
  • The effect of market expansion re-pricing rules
  • Exploration into the efforts to increase the uptake of generics and the impact of this on branded manufacturers
  • Advantages in the Japanese pharmaceutical market

 

Japanese Pharamaceutical

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or email us your inquiry, so we can provide you the best possible customer service:
pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: